Join the Cerebral Palsy group to help and get support from people like you.
Cerebral Palsy News
Could Caffeine in Pregnancy Help Prevent Cerebral Palsy in Kids?
TUESDAY, Oct. 22, 2024 – Experiments in sheep are hinting that doses of caffeine given to women in pregnancy, as well as their newborns after birth, could prevent cerebral palsy. Cerebral palsy is a...
Pain Diagnoses Seen for Most Patients With Cerebral Palsy
WEDNESDAY, Aug. 14, 2024 – Most patients (89.0 percent) with cerebral palsy (CP) have one or more documented pain diagnoses, according to a research letter published online Aug. 5 in JAMA Neurology....
BoNT-A Does Not Affect Gross Energy Cost of Walking in Cerebral Palsy
MONDAY, Aug. 12, 2024 – For children with cerebral palsy (CP), a single injection of botulinum neurotoxin A (BoNT-A) into the calf muscles does not affect the gross energy cost of walking, according...
Fear of Falls, Injuries Can Plague Motorized Wheelchair Users
TUESDAY, August 6, 2024 (HealthDay News) — When people who use wheelchairs or motorized scooters get hurt in a fall, fear that it will happen again may keep them on the sidelines of life, a new study ...
Here Are the Barriers Keeping People With Disabilities From Exercise
MONDAY, Aug. 5, 2024 – Many people with disabilities aren’t getting the exercise they need because fitness centers don’t offer adaptive equipment or staff trained in helping the disabled, a new rev...
Robot-Assisted Gait Training Beneficial for Children With Cerebral Palsy
TUESDAY, July 30, 2024 – Overground robot-assisted gait training (RAGT) using a wearable robot improves gross motor function and gait pattern in children with cerebral palsy (CP), according to a...
Prenatal Fine Particulate Matter Exposure Linked to Cerebral Palsy
FRIDAY, July 12, 2024 – Prenatal ambient fine particulate matter (PM2.5) exposure is associated with an increased risk for cerebral palsy, according to a study published online July 9 in JAMA...
Ipsen Biopharmaceuticals, Inc. Announces FDA Approval of Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Pediatric Patients Aged Two and Older
BASKING RIDGE, N.J., Aug. 1, 2016 /PRNewswire/ – Ipsen Biopharmaceuticals, Inc., a subsidiary of Ipsen SA (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that the U.S. Food and Drug...